Predicting Response to PRRT: Development and Validation of a Blood-Based Predictive Biomarker

被引：0
|
作者：
Bodei, L. [1 ]
Kidd, M. [2 ]
Van der Zwan, W. [3 ]
Singh, A. [4 ]
Severi, S. [5 ]
Drozdov, I [2 ]
Cwikla, J. [6 ]
Baum, R. P. [7 ]
Paganelli, G. [5 ]
Kwekkeboom, D. [3 ]
Krenning, E. [3 ]
Modlin, I [8 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Wren Labs, Branford, CT USA
[3] Erasmus MC, Rotterdam, Netherlands
[4] Zentra, Bad Berka, Germany
[5] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy
[6] Univ Warmia & Mazury, Olsztyn, Poland
[7] Zent Klin Bad Berka, Bad Berka, Germany
[8] Yale Univ, New Haven, CT USA
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
biomarker; carcinoid; prrt; prediction; therapy; efficacy; stratification;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
K03
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [1] Blood-based biomarkers predicting response to antidepressants
    Busch, Yasmin
    Menke, Andreas
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (01) : 47 - 63
  • [2] Blood-based biomarkers predicting response to antidepressants
    Yasmin Busch
    Andreas Menke
    [J]. Journal of Neural Transmission, 2019, 126 : 47 - 63
  • [3] Validation of I-FABP as a Blood-Based Biomarker of EED
    Qiu, Selinda Y.
    Hoke, Morgan K.
    [J]. AMERICAN JOURNAL OF HUMAN BIOLOGY, 2022, 34
  • [4] Validation of Blood-Based Biomarker for Classification of Patients with Indeterminate Pulmonary Nodules
    Tomic, Jennifer L.
    Lagier, Robert L.
    Pass, Harvey I.
    Rom, William N.
    Pollard, Thomas R.
    Birse, Charlie E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S306 - S307
  • [5] Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC
    Oitaben, Ana
    Fonseca, Pablo
    Villanueva, Maria J.
    Garcia-Benito, Carme
    Lopez-Lopez, Aida
    Garrido-Fernandez, Alberto
    Gonzalez-Ojea, Clara
    Juaneda-Magdalena, Laura
    Lazaro, Martin E.
    Martinez-Fernandez, Monica
    [J]. CANCERS, 2022, 14 (11)
  • [6] Assessing the predictive response of a simple and sensitive blood-based biomarker between estrogen-negative solid tumors
    Mohan, Srinidi
    Patel, Seema
    Barlow, David
    Rojas, Augusto Cardenas
    [J]. ADVANCES IN MEDICAL SCIENCES, 2020, 65 (02): : 424 - 428
  • [7] A blood-based biomarker for checkpoint inhibition
    Hannah Stower
    [J]. Nature Medicine, 2018, 24 (12) : 1781 - 1781
  • [8] Validation of a Blood-Based Biomarker Test for the Diagnosis and Management of Bronchopulmonary Neuroendocrine Tumors
    Modlin, I
    Kidd, M.
    Lewczuk-Myslinska, A.
    Chung, K. M.
    Cwikla, J.
    Lowczak, A.
    Doboszynska, A.
    Tesselaar, M.
    Buikhuisen, W.
    Malczewska, A.
    Kos-Kudla, B.
    Roffinella, M.
    [J]. NEUROENDOCRINOLOGY, 2018, 106 : 294 - 294
  • [9] Calretinin as a blood-based biomarker for mesothelioma
    Johnen, Georg
    Gawrych, Katarzyna
    Raiko, Irina
    Casjens, Swaantje
    Pesch, Beate
    Weber, Daniel G.
    Taeger, Dirk
    Lehnert, Martin
    Kollmeier, Jens
    Bauer, Torsten
    Musk, Arthur W.
    Robinson, Bruce W. S.
    Bruening, Thomas
    Creaney, Jenette
    [J]. BMC CANCER, 2017, 17
  • [10] A blood-based prognostic biomarker in IBD
    Biasci, Daniele
    Lee, James C.
    Noor, Nurulamin M.
    Pombal, Diana R.
    Hou, Monica
    Lewis, Nina
    Ahmad, Tariq
    Hart, Ailsa
    Parkes, Miles
    McKinney, Eoin F.
    Lyons, Paul A.
    Smith, Kenneth G. C.
    [J]. GUT, 2019, 68 (08) : 1386 - 1395
12345